CellSource Co

CellSource Co Revenue per Share

The Revenue per Share of CellSource Co (4880.T) as of Oct 27, 2026 is 187.26 JPY. In the previous year, Revenue per Share was 219.89 JPY — a change of -14.84% (lower).

Revenue per Share

187.26JPY

YoY

-14.84%

Last updated:

Revenue per Share of CellSource Co is 2025 187.26 JPY. Revenue per Share of CellSource Co was 2024 219.89 JPY. It decreases by -14.84% lower compared to the previous year.

The CellSource Co Revenue per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
Date
Revenue per Share
Jan 1, 2022
222.43 JPY
Jan 1, 2023
232.51 JPY
Jan 1, 2024
219.89 JPY
Jan 1, 2025
187.26 JPY
Jan 1, 2026 (e)
169.94 JPY
Jan 1, 2027 (e)
176.50 JPY
Jan 1, 2028 (e)
196.67 JPY
Jan 1, 2029 (e)
306.20 JPY
The CellSource Co Revenue per Share history
YEARRevenue per ShareYoY
est306.20JPY+55.69%
est196.67JPY+11.43%
est176.50JPY+3.86%
est169.94JPY-9.25%
187.26JPY-14.84%
219.89JPY-5.43%
232.51JPY+4.53%
222.43JPY+46.26%
152.08JPY+57.10%
96.80JPY+3.79%
93.26JPY+53.02%
60.95JPY+133.64%
26.09JPY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CellSource Co Stock analysis

What does CellSource Co do? CellSource Co., Ltd. generates revenue through its Regenerative Medicine Related business segment, which provides contracted services for processing tissues and cells from fat and blood to medical institutions, along with support services for regenerative medicine laws and regulations related to safety assurance. The company also sells medical equipment within this segment. The Consumer business segment focuses on selling cosmetics and facial products directly to general consumers. Both segments operate under the company's brand without additional brand names mentioned in the description. The Regenerative Medicine Related business segment targets medical institutions and regulatory compliance support for regenerative medicine safety, while the Consumer business segment serves general consumers seeking cosmetics and facial care products. The company's products include processed tissue and cell services, regulatory support, medical equipment, and consumer skincare items, all sold under the CellSource brand. CellSource Co., Ltd. employs 109 full-time employees to manage its two business segments, with the Regenerative Medicine Related segment handling medical services and equipment sales, and the Consumer segment focusing on direct-to-consumer product sales. The company's revenue streams are derived from these two distinct operational areas without any additional external partnerships or third-party brands. CellSource Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CellSource Co stock

Revenue per Share of CellSource Co is 187.26 JPY in 2025.

Revenue per Share of CellSource Co changed from 219.89 JPY to 187.26 JPY, representing a -14.84% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Revenue per Share CellSource Co since 2006 – with annual values, charts, and detailed analysis.

Revenue per Share divides total revenue by shares outstanding, showing how much revenue each share represents.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — CellSource Co

All Key Metrics — CellSource Co